• [Diamond Jubilee]

Researchers Honoured

Queen Elizabeth II Diamond Jubilee Medal Recipients

Nine members of the Queen’s community are recipients of the Queen Elizabeth II Diamond Jubilee Medal.

The Queen Elizabeth II Diamond Jubilee Medal was created in 2012 to honour Her Majesty for her service to Canada, while also honouring significant contributions and achievements by Canadians.

Recipients include:

  • Daniel Woolf

    Daniel Woolf (Principal and Vice-Chancellor) was recognized for being a passionate champion for student mental health and wellness.

  • [Wendy Craig]

    Wendy Craig (Psychology) was recognized for her leadership in knowledge mobilization on bullying and healthy relationships to improve the lives of Canadian children and youth.

  • [Elizabeth Eisenhower]

    Elizabeth Eisenhauer (Oncology) was recognized for her commitment to the advancement of cancer therapy, supportive care and prevention across Canada and internationally.

  • [T. Geoffrey Flynn]

    T. Geoffrey Flynn (Biomedical and Molecular Sciences) was recognized for his commitment to the advancement of science, through his support of both research and teaching excellence.

  • [Will Kymlicka]

    Will Kymlicka (Philosophy) was recognized as one of the world’s leading experts on the role of minority rights within liberal-democratic theory.

  • [Steven Liss]

    Steven Liss (Vice-Principal, Research) was recognized for his role in leading the promotion, development and advancement of research across disciplines in Canada.

  • [Kerry Rowe]

    Kerry Rowe (Civil Engineering) has made award-winning contributions to the investigation of landfill development, soft-ground tunneling and the reinforcement of embankments.

  • [John Smol]

    John Smol (Biology) was recognized for his contributions to identifying changes in the world’s water environment and bringing this research to the public.

  • [Susan Cole]

    Susan P.C. Cole (Pathology) was recognized for her contributions to cancer research focused on the study of the biochemical and molecular mechanisms that limit the effectiveness of cancer chemotherapy.